Evidence map›Paper›PMID 26682812›Full record

ArticleBiophysical journal2015

Modification of Salmonella Lipopolysaccharides Prevents the Outer Membrane Penetration of Novobiocin.

Thatyane M Nobre, Michael W Martynowycz, Konstantin Andreev, Ivan Kuzmenko, Hiroshi Nikaido, David Gidalevitz

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Defense mechanisms ofFrontiers in antibiotics · 2024
    Review
  6. Article
  7. A Single Nucleotide Polymorphism inFrontiers in microbiology · 2021
    Article
  8. Structural Changes in Films of Pulmonary Surfactant Induced by Surfactant Vesicles.Langmuir : the ACS journal of surfaces and colloids · 2020
    Article
  9. Review
  10. ACS infectious diseases · 2019
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Campylobacteriosis, Salmonellosis, Yersiniosis, and Listeriosis as Zoonotic Foodborne Diseases: A Review.International journal of environmental research and public health · 2018
    Review
  17. Article
  18. Cyclization Improves Membrane Permeation by Antimicrobial Peptoids.Langmuir : the ACS journal of surfaces and colloids · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Thatyane M NobreDepartment of Molecular and Cell Biology, University of California at Berkeley, Berkeley, California; Molecular Foundry, Lawrence Berkeley National Laboratory, Berkeley, California. Electronic address: thatty@ursa.ifsc.usp.br.
Michael W MartynowyczCenter for Molecular Study of Condensed Soft Matter and Department of Physics, Illinois Institute of Technology, Chicago, Illinois; X-ray Science Division, Advanced Photon Source, Argonne National Laboratory, Lemont, Illinois.
Konstantin AndreevCenter for Molecular Study of Condensed Soft Matter and Department of Physics, Illinois Institute of Technology, Chicago, Illinois.
Ivan KuzmenkoX-ray Science Division, Advanced Photon Source, Argonne National Laboratory, Lemont, Illinois.
Hiroshi NikaidoDepartment of Molecular and Cell Biology, University of California at Berkeley, Berkeley, California.
David GidalevitzCenter for Molecular Study of Condensed Soft Matter and Department of Physics, Illinois Institute of Technology, Chicago, Illinois. Electronic address: gidalevitz@iit.edu.
Illinois Institute of Technology · USArgonne National Laboratory · USLawrence Berkeley National Laboratory · USUniversity of California, Berkeley · US

Funding

BIOCHEMISTRY OF BACTERIAL CELL MEMBRANESR01AI009644 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI NIKAIDO, HIROSHI · 1985 to 2015
$9.7M
Antimicrobial Peptides and their Synthetic Mimics - Investigating the Mechanism oR01AI073892 · NIAID · ILLINOIS INSTITUTE OF TECHNOLOGY · PI GIDALEVITZ, DAVID · 2008 to 2011
$1.2M
BIOCHEMISTRY OF BACTERIAL CELL MEMBRANESR37AI009644 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI NIKAIDO, HIROSHI · 1991 to 2000
$467k
NIAID NIH HHS AI009644NIAID NIH HHS AI073892NIAID NIH HHS R01 AI009644NIAID NIH HHS R01 AI073892NIAID NIH HHS R37 AI009644
6 · The paper itself

Abstract

Small hydrophilic antibiotics traverse the outer membrane of Gram-negative bacteria through porin channels. Large lipophilic agents traverse the outer membrane through its bilayer, containing a majority of lipopolysaccharides in its outer leaflet. Genes controlled by the two-component regulatory system PhoPQ modify lipopolysaccharides. We isolate lipopolysaccharides from isogenic mutants of Salmonella sp., one lacking the modification, the other fully modified. These lipopolysaccharides were reconstituted as monolayers at the air-water interface, and their properties, as well as their interaction with a large lipophilic drug, novobiocin, was studied. X-ray reflectivity showed that the drug penetrated the monolayer of the unmodified lipopolysaccharides reaching the hydrophobic region, but was prevented from this penetration into the modified lipopolysaccharides. Results correlate with behavior of bacterial cells, which become resistant to antibiotics after PhoPQ-regulated modifications. Grazing incidence x-ray diffraction showed that novobiocin produced a striking increase in crystalline coherence length, and the size of the near-crystalline domains.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsCell MembraneHydrophobic and Hydrophilic InteractionsLipid ALipopolysaccharidesNovobiocinPermeabilitySalmonellaAnti-Bacterial AgentsBacterial ProteinsLipid ALipopolysaccharidesNovobiocin

Identifiers

PMID26682812
PMCPMC4699856
OpenAlexW2218403659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.